Soluble P-selectin as a potential diagnostic and prognostic biomarker for COVID-19 disease: A case-control study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Soluble P-selectin as a potential diagnostic and prognostic biomarker for COVID-19 disease: A case-control study

Published:2021-07 Issue: Volume:277 Page:119634
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Karsli Emre,Sabirli Ramazan,Altintas Emel,Canacik Omer,Sabirli Gizem Tukenmez,Kaymaz Buse,Kurt Özgür,Koseler Aylin

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference35 articles.

1. Association between laboratory parameters and CT severity in patients infected with COVID-19: a retrospective, observational study;Yilmaz;Am. J. Emerg. Med.,2021

2. Serum S100B protein as a marker of severity in COVID-19 patients;Aceti;Sci. Rep.,2020

3. D-dimer as a potential biomarker for disease severity in COVID-19;Ozen;Am. J. Emerg. Med.,2021

4. Neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio and platelet to lymphocyte ratio to predict the severity of COVID-19;Seyit;Am. J. Emerg. Med.,2020

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application value of P‐selectin and Clara cell secretory protein 16 expression in children with severe adenovirus pneumonia;Journal of Medical Virology;2024-09

2. Identification of key genes and biological pathways in chronic obstructive pulmonary disease using bioinformatics and next generation sequencing data analysis;2024-02-14

3. Viral uptake and pathophysiology of the lung endothelial cells in age‐associated severe SARS‐CoV‐2 infection models;Aging Cell;2023-12-14

4. Symmetrical peripheral gangrene: potential mechanisms and therapeutic approaches in severe COVID-19;Frontiers in Cardiovascular Medicine;2023-11-29

5. Exploring dysregulated immune response genes and endothelial dysfunction biomarkers as predictors of severe COVID-19;International Immunopharmacology;2023-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3